Hoth Therapeutics, Inc.
HOTH
$1.23
-$0.05-3.91%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/9/2025
-
MarketBeat
10/27/2025
-
GuruFocus
10/27/2025
-
PR Newswire
10/21/2025
-
GuruFocus
10/21/2025
-
GuruFocus
10/21/2025
-
Seeking Alpha - Healthcare
10/21/2025
-
The Fly
10/21/2025
-
PR Newswire
10/17/2025
-
TipRanks Financial Blog
10/8/2025
-
GuruFocus
10/8/2025
-
The Fly
10/8/2025
-
PR Newswire
10/7/2025
-
GuruFocus
10/7/2025
-
PR Newswire
9/24/2025
-
GuruFocus
9/24/2025
-
GuruFocus
9/24/2025
-
The Fly
9/24/2025
-
PR Newswire
9/23/2025
-
Insider Monkey
9/21/2025
-
Insider Monkey
9/16/2025
-
GuruFocus
9/16/2025
-
PR Newswire
9/13/2025
-
Ticker Report
9/10/2025
-
GuruFocus
9/10/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(646) 756-2997
Address
1177 Avenue of the Americas
Suite 5066 - 5th Floor
New York, NY 10036
Suite 5066 - 5th Floor
New York, NY 10036
Country
Year Founded
Business Description
Sector
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial...
more